Mobile Phone Text for Optimizing Asthma Treatment

This study has been completed.
Sponsor:
Collaborators:
MedicoMonitor Aps
The Ministry of Health and Prevention, Denmark
Information provided by:
University of Copenhagen
ClinicalTrials.gov Identifier:
NCT00917410
First received: June 5, 2009
Last updated: June 9, 2009
Last verified: June 2009
  Purpose

The study aims at providing information on how the Short Message Service (SMS) tool influences self-management in asthma patients and to assess the resulting health related effect. A wide range of models and theories exist in the compliance area, such as technical models, communication models, cognitive models and self-management models and theories. The use of some of these theories and models will serve as theoretical and explanatory tools for studying how and why the SMS tool influences the patient's self-management.

Objective:

The objective of this study is to assess the health-related effects of a SMS compliance and monitoring system for optimized asthma treatment in a controlled trial setting.


Condition Intervention
Asthma
Behavioral: SMS support

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Assessment of the Health Related Effects of Compliance Optimization in Asthma Through Use of SMS (Short Message System) - A Controlled Trial

Further study details as provided by University of Copenhagen:

Primary Outcome Measures:
  • Asthma control test [ Designated as safety issue: No ]
  • EQ-5D [ Time Frame: 0, 45, 90 days ] [ Designated as safety issue: No ]
  • Use of health services [ Time Frame: 0, 45, 90 days ] [ Designated as safety issue: No ]
  • Use of preventive medicine [ Time Frame: 0, 45, 90 days ] [ Designated as safety issue: No ]

Enrollment: 244
Study Start Date: November 2007
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: SMS intervention Behavioral: SMS support

The intervention consisted of sequences of SMS messages sent to the intervention group, each containing 2 or 3 monitoring questions and one reminder to take the preventive medication. The SMS sequence was as follows.

  1. Remember to take your preventive asthma medication (sent at 8.00 am).
  2. Were you awakened during the night due to your asthma? Answer YES or NO.
  3. How many times have you taken your asthma attack medication during the last 24 hours? Answer a number.
  4. What was your peak flow this morning? Answer a number (optional, depending on the participant's use of a spirometer prior to the study).

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • asthmatics

Exclusion Criteria:

  • below 18 and above 45
  • COPD patients
  • no mobile phone
  • not using the prescribed asthma inhalation medication
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00917410

Locations
Denmark
University of Copenhagen
Copenhagen, Denmark, 2100
Sponsors and Collaborators
University of Copenhagen
MedicoMonitor Aps
The Ministry of Health and Prevention, Denmark
Investigators
Principal Investigator: Claus Møldrup, PhD University of Copenhagen
  More Information

No publications provided

Responsible Party: Claus Møldrup, Associate Professor PhD, University of Copenhagen
ClinicalTrials.gov Identifier: NCT00917410     History of Changes
Other Study ID Numbers: UC-SMS-01
Study First Received: June 5, 2009
Last Updated: June 9, 2009
Health Authority: Denmark: Danish Dataprotection Agency

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 30, 2014